Anti-Retroviral (ARV) Drugs or Anti-Retroviral Therapy (ART)
Although the scale of coverage of people on antiretroviral drugs has increased from less than 5% to about 25% in 2007, there are still millions of people in Nigeria who need treatment, including children.
- Treatment and care: unprecedented progress, remaining challenges
- Nigeria: Progress towards Universal Access and The Declaration of Commitment on HIV/AIDS
- 2008 Report on the global AIDS epidemic
- Uniting the world against AIDS
- UNAIDS: Report on the global AIDS epidemic
Treatment with quality drug products suitable for children’s needs is important to DAHP. One of the companies that make this a primary goal (Elim Pediatric Pharmaceuticals Inc) will partner with DAHP in the nearest future in order to make this a reality.